Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Vacaresse, N; Vieira, O; Robbesyn, F; Jürgens, G; Salvayre, R; Negre-Salvayre, A.
Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation.
Br J Pharmacol. 2001; 132(8):1777-1788 Doi: 10.1038/sj.bjp.0703981 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Jürgens Günther
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Oxidized low density lipoproteins (oxLDL) are thought to play a major role in atherosclerosis. OxLDL act in part through alteration of intracellular signalling pathways in cells of the vascular wall. We recently reported that the EGF receptor (EGFR) signalling pathway is activated by lipid peroxidation products (among them 4-hydroxynonenal, 4-HNE) contained in oxLDL. The use of phenolic antioxidants, such as trolox, alpha-tocopherol, caffeic acid and tyrphostins A-25, A-46 or A-1478, showed that the oxLDL-induced EGFR activation is constituted by two separate components, the first (early) one being antioxidant-insensitive, the second (late) being antioxidant-sensitive. 4-HNE derivatization of EGFR and EGFR activation induced by exogenous 4-HNE, suggest that the early (0.5 - 3 h) component of oxLDL-induced EGFR activation is mediated (at least in part) by 4-HNE (and possibly by other oxidized lipids). This early component is antioxidant-insensitive. The second component (4 - 5 h) of the oxLDL-induced EGFR activation is antioxidant-sensitive, since it is blocked by antioxidants such as trolox, caffeic acid or PDTC, which act by blocking the cellular oxidative stress (H(2)O(2) generation) evoked by oxLDL. Conversely, exogenous H(2)O(2) induced EGFR autophosphorylation (thus mimicking the second component) and was also inhibited by antioxidants. This effect is mediated in part through inhibition by oxidative stress of protein tyrosine phosphatases involved in EGFR dephosphorylation.
Find related publications in this database (using NLM MeSH Indexing)
Aldehydes - pharmacology
Antioxidants - pharmacology
Biotransformation - drug effects
Blotting, Western - drug effects
Caffeic Acids - pharmacology
Cell Line - pharmacology
Chromans - pharmacology
Cross-Linking Reagents - pharmacology
Humans - pharmacology
Hydrogen Peroxide - pharmacology
Lipoproteins, LDL - antagonists and inhibitors
Oxidation-Reduction - antagonists and inhibitors
Phosphorylation - antagonists and inhibitors
Precipitin Tests - antagonists and inhibitors
Protein-Tyrosine Kinases - metabolism
Protein-Tyrosine-Phosphatase - antagonists and inhibitors
Receptor, Epidermal Growth Factor - drug effects

Find related publications in this database (Keywords)
oxidized LDL
EGF-receptor
4-hydroxynonenal
tyrosine phosphorylation
caffeic acid
trolox
antioxidants
atherosclerosis
© Med Uni Graz Impressum